Identification of functional farnesoid X receptors in brain neurons

FEBS Letters

Volumn 590, Issue 18, 2016, Pages 3233-3242

  Huang, Chao ^a,b   Wang, Jili ^a,b   Hu, Wenfeng ^a,b   Wang, Chengniu ^a   Lu, Xu ^a,b   Tong, Lijuan ^a,b   Wu, Feng ^a,b   Zhang, Wei ^a,b  

^a NANTONG UNIVERSITY   (China)

^b Key Laboratory of Inflammation and Molecular Drug Target of Jiangsu   (China)

Author keywords

brain; farnesoid X receptor; neuron; small heterodimer partner

Indexed keywords

FARNESOID X RECEPTOR; MESSENGER RNA; PREGNANE X RECEPTOR; SMALL INTERFERING RNA; VITAMIN D RECEPTOR; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; BRAIN NERVE CELL; CELL CULTURE; CENTRIFUGATION; CONTROLLED STUDY; CYTOPLASM; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LETTER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING; ANIMAL; BRAIN; C57BL MOUSE; CELL NUCLEUS; CYTOLOGY; GENETICS; METABOLISM; NERVE CELL;

ANIMALS; BRAIN; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; MALE; MICE; MICE, INBRED C57BL; NEURONS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER;

EID: 84984829485     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12373     Document Type: Article

References (31)

1. Monte MJ, Marin JJ, Antelo A and Vazquez-Tato J (2009) Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol 15, 804–816.
2. Perez MJ and Briz O (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol 15, 1677–1689.
3. Sharanek A, Burban A, Humbert L, Bachour-El Azzi P, Felix-Gomes N, Rainteau D and Guillouzo A (2015) Cellular accumulation and toxic effects of bile acids in cyclosporine A-treated HepaRG hepatocytes. Toxicol Sci 147, 573–587.
4. Schaap FG, Trauner M and Jansen PL (2014) Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol 11, 55–67.
5. Kumar DP, Rajagopal S, Mahavadi S, Mirshahi F, Grider JR, Murthy KS and Sanyal AJ (2012) Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem Biophys Res Commun 427, 600–605.
6. Stepanov V, Stankov K and Mikov M (2013) The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J Recept Signal Transduct Res 33, 213–223.
7. Chen X, Lou G, Meng Z and Huang W (2011) TGR5: a novel target for weight maintenance and glucose metabolism. Exp Diabetes Res 2011, 853501.
8. Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E and Baldelli F (2010) Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med 10, 579–595.
9. Zollner G, Marschall HU, Wagner M and Trauner N (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3, 231–251.
10. Manley S and Ding W (2015) Role of farnesoid X receptor and bile acids in alcoholic liver disease. Acta Pharm Sin B 5, 158–167.
11. Dossa AY, Escobar O, Golden J, Frey MR, Ford HR and Gayer CP (2016) Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling. Am J Physiol Gastrointest Liver Physiol 310, G81–G92.
12. Bae EH, Choi HS, Joo SY, Kim IJ, Kim CS, Choi JS, Ma SK, Lee J and Kim SW (2014) Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner. PLoS One 9, e86553.
13. Lee H, Zhang Y, Lee FY, Nelson SF, Gonzalez FJ and Edwards PA (2006) FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. J Lipid Res 47, 201–214.
14. Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, Lau WB, Koch W, Ma XL and He B (2013) Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury. Eur Heart J 34, 1834–1845.
15. Zhang R, Ran HH, Zhang YX, Liu P, Lu CY, Xu Q and Huang Y (2012) Farnesoid X receptor regulates vascular reactivity through nitric oxide mechanism. J Physiol Pharmacol 63, 367–372.
16. Li C, Li J, Weng X, Lan X and Chi X (2015) Farnesoid X receptor agonist CDCA reduces blood pressure and regulates vascular tone in spontaneously hypertensive rats. J Am Soc Hypertens 9 (507–516), e7.
17. He X, Xu Z, Wang B, Zheng Y, Gong W, Huang G, Zhang L, Li Y and He F (2013) Upregulation of thrombomodulin expression by activation of farnesoid X receptor in vascular endothelial cells. Eur J Pharmacol 718, 283–289.
18. Huang F, Wang T, Lan Y, Yang L, Pan W, Zhu Y, Lv B, Wei Y, Shi H, Wu H et al. (2015) Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior. Front Behav Neurosci 9, 70.
19. Bauer B, Hartz AM, Lucking JR, Yang X, Pollack GM and Miller DS (2008) Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J Cereb Blood Flow Metab 28, 1222–1234.
20. Aghaei I, Hajali V, Dehpour A, Haghani M, Sheibani V and Shabani M (2015) Alterations in the intrinsic electrophysiological properties of Purkinje neurons in a rat model of hepatic encephalopathy: relative preventing effect of PPARγ agonist. Brain Res Bull 121, 16–25.
21. Huang C, Wang Y, Wang J, Yao W, Chen X & Zhang W (2013) TSG (2,3,4′,5-tetrahydroxystilbene 2-O-β-D-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia. J Neuroinflammation 10, 129.
22. Renga B, Mencarelli A, Vavassori P, Brancaleone V and Fiorucci S (2010) The bile acid sensor FXR regulates insulin transcription and secretion. Biochim Biophys Acta 1802, 363–372.
23. Popescu IR, Helleboid-Chapman A, Lucas A, Vandewalle B, Dumont J, Bouchaert E, Derudas B, Kerr-Conte J, Caron S, Pattou F et al. (2010) The nuclear receptor FXR is expressed in pancreatic beta-cells protects human islets from lipotoxicity. FEBS Lett 584, 2845–2851.
24. Seok S, Fu T, Choi SE, Li Y, Zhu R, Kumar S, Sun X, Yoon G, Kang Y, Zhong W et al. (2014) Transcriptional regulation of autophagy by an FXR-CREB axis. Nature 516, 108–111.
25. Schmidt DR, Schmidt S, Holmstrom SR, Makishima M, Yu RT, Cummins CL, Mangelsdorf DJ and Kliewer SA (2011) AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids. J Biol Chem 286, 2425–2432.
26. Chennamsetty I, Claudel T, Kostner KM, Baghdasaryan A, Kratky D, Levak-Frank S, Frank S, Gonzalez FJ, Trauner M and Kostner GM (2011) Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest 121, 3724–3734.
27. Renga B, Migliorati M, Mencarelli A, Cipriani S, D'Amore C, Distrutti E and Fiorucci S (2011) Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter. Biochim Biophys Acta 1809, 157–165.
28. McMillin M, Frampton G, Quinn M, Ashfaq S, deLos Santos M 3rd, Grant S & DeMorrow S (2016) Bile acid signaling is involved in the neurological decline in a murine model of acute liver failure. Am J Pathol 186, 312–323.
29. Mano N, Goto T, Uchida M, Nishimura K, Ando M, Kobayashi N and Goto J (2004) Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain. J Lipid Res 45, 295–300.
30. McMillin M, Frampton G, Tobin R, Dusio G, Smith J, Shin H, Newell-Rogers K, Grant S and DeMorrow S (2015) TGR5 signaling reduces neuroinflammation during hepatic encephalopathy. J Neurochem 135, 565–576.
31. Keitel V, Görg B, Bidmon HJ, Zemtsova I, Spomer L, Zilles K and Häussinger D (2010) The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia 58, 1794–1805.